Creatine Kinase-MB (CK-MB) Rapid Test Device (Whole Blood/Serum/Plasma)

Product Description

The Creatine Kinase-MB (CK-MB) Rapid Test Device is a point-of-care diagnostic tool designed for the rapid and qualitative detection of CK-MB isoenzyme in whole blood, serum, or plasma samples. CK-MB is a cardiac marker, and elevated levels are indicative of myocardial injury, often associated with acute myocardial infarction (AMI) or other cardiac events. This device offers a convenient and efficient method for initial assessment of patients suspected of experiencing cardiac damage, aiding in timely diagnosis and treatment decisions. The test utilizes a simple procedure, providing results within minutes, allowing for rapid clinical intervention where appropriate. The device is intended for use by healthcare professionals in various settings.

Features

Rapid results (within 15 minutes)
Easy-to-use format (cassette-based)
Suitable for Point-of-Care testing

Specifications

Parameter	Specification
Detection Target	Creatine Kinase-MB (CK-MB)
Sample Type	Whole Blood, Serum, Plasma
Methodology	Immunochromatography
Detection Range	Positive/Negative (Qualitative)
Reaction Time	10-15 minutes
Storage Conditions	2-30°C
Shelf Life	18 months

Product Advantages

Early Screening Tool

Helps quickly identify infected individuals, implement timely isolation measures, and control the spread of the epidemic.

Suitable for Multiple Scenarios

Suitable for various scenarios such as home self-testing, corporate screening, schools, and clinics.

Reliable Quality

Strict quality control system ensures stable and reliable product performance.

Instructions for Use

Read the instructions carefully.
Prepare sample collection tools and the test kit.
Collect the sample according to the instructions.
Add the sample to the test cassette.
Wait 15 minutes to read the results.

Certification Information

CE Certified
ISO13485

Interested in Creatine Kinase-MB (CK-MB) Rapid Test Device (Whole Blood/Serum/Plasma)?

Back to Products Request Quote